- Oops!Something went wrong.Please try again later.
New York, April 30, 2020 (GLOBE NEWSWIRE) -- Trxade Group Inc. Featured in Broadcast on Companies Aiding Coronavirus Front Lines
NEW YORK (April 30, 2019) – via NetworkNewsAudio –Trxade Group Inc. (MEDS) announces the availability of a broadcast titled, “Medical Supply Companies Take on Crucial Role in Combatting Coronavirus.”
To hear the AudioPressRelease from NetworkNewsAudio please visit:
To read the full editorial version please visit: http://nnw.fm/pmzJ6.
Getting supplies to where they’re needed depends on the integrity of the supply chain. Both consumer-facing and business-to-business (B2B) distribution systems need to function at high effectiveness to distribute drugs, personal protective equipment (PPE), and other supplies to fight the stealth-like spread of this pathogen.
Trxade Group Inc. (MEDS) provides indispensable elements in that supply chain. On the B2B side, the company provides purchasing systems for over 10,000 independent pharmacies – more than a third of the independent pharmacies operating in the U.S. – facilitating over $10 million in drug sales per month. For consumers, its Delivmeds app and full-service mail order system help patients get their medications on the same day that they order them, with minimal social contact.
About Trxade Group Inc.
Headquartered in Tampa, Florida, Trxade Group Inc. (MEDS) is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to buyers and sellers of pharmaceuticals, makes Healthcare services affordable and accessible across all 50 states, and steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms: the Trxade B2B trading platform with 12,100 registered pharmacies, a licensed virtual Wholesaler, affordable healthcare via its Bonum Health app or web-based telehealth services, and Same Day or Mail Order Pharmacy delivery capabilities via its DelivMeds app featuring its extensive nationwide distribution network. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.
NetworkNewsAudio (“NNA”) allows you to sit back and listen to market updates, CEO interviews and a company AudioPressRelease (“APR”). These audio clips provide snapshots of position, opportunity and momentum. NNA can assist your company by cutting through the overload of information in today's market. NNA brings its Client Partners unparalleled visibility, recognition and brand awareness. NNA is just one site within our sizable family of 40+ brands within the InvestorBrandNetwork (“IBN”). IBN is a comprehensive provider of news and original articles; we aggregate and syndicate this content for much bigger impact. IBN also adds Press Release Enhancement and a full array of social media communication solutions and has amassed a collective audience that includes millions of social media followers. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, IBN has the unparalleled ability to reach a wide audience comprising investors, consumers, journalists and the general public with an ever-growing distribution network of 5,000+ key syndication outlets across the nation.
For more information, please visit:
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.